Clever Leaves Announces First Export to Israeli Partner InterCure
BOCA RATON, Fla. – Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the first commercial export to Israel of high THC Flower for medical use from its facility in Portugal through its partnership with InterCure (Nasdaq: INCR, TSX: INCR.U, TASE: INCR). With this initial shipment, medical cannabis patients in Israel will now have access to Clever Leaves’ cannabis flower grown in its IMC-GAP equivalent cultivation facilities.
Clever Leaves will first supply InterCure with a high THC strain followed by several other genetics that will arrive, as part of the long-term partnership agreement between the companies previously announced.
“Our partnership with InterCure has been a long time in the making and we are thrilled to be working with one of the most prominent names in Israeli medical cannabis,” said Andrés Fajardo, CEO of the Company. “Israel has been a strategic market focus for Clever Leaves and InterCure’s position as a market leader further solidifies our plans for growth in the region. In addition to this being representative of our continued global expansion, it proves that our products can meet the most stringent regulatory standards in the world.”
Complementing the Company’s plans to continue distributing high-quality flower to medical patients, Clever Leaves will cultivate Canndoc’s proprietary genetics in its Colombia and Portugal facilities, meeting all regulatory and compliance standards, for distribution across Israel and other countries.
Alex Rabinovitch, CEO of InterCure, said: “We’re delighted to see the first fruit of our successful partnership with Clever Leaves. This first importation is just the first step for our long-term partnership and an attestment to the abilities of our teams to meet the challenging strict regulatory requirements of the Israeli pharmaceutical grade medical cannabis market.”
(This information is primarily sourced from Clever Leaves. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
Latest News
Cannabis Extraction Market: An In-depth Analysis from 2018-2027
Douglas, Isle Of Man - Cannabis extraction and extract have gone through exponential growth in the past decade. After being criminalized for a long time, the world saw and moved towards legalizing cannabis in many ...
Bright Green Issues Statement of Intent on Illegal Short Selling Activities
GRANTS, N.M. - Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, ...
Global Cannabis Testing Market Analysis Report 2023-2030
DUBLIN - Global Cannabis Testing Market to Reach $2.8 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Cannabis Testing estimated at US$1.1 Billion in the year 2022, is projected to reach ...